Literature DB >> 15135396

Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.

Timothy I Meier1, James A Cook, James E Thomas, Jeffrey A Radding, Candice Horn, Trupti Lingaraj, Michele C Smith.   

Abstract

The Class I phosphoinositide 3-kinases (PI3Ks) are lipid kinases that phosphorylate the 3-hydroxyl group of the inositol ring of phosphatidylinositides. Although closely related, experimental evidence suggests that the four Class I PI3Ks may be functionally distinct. To further study their unique biochemical properties, the three human Class Ia PI3K (alpha, beta, and delta) p110 catalytic domains were cloned and co-expressed with the p85alpha regulatory domain in Sf9 cells. None of the p110 subunits were successfully expressed in the absence of p85alpha. Successful expression and purification of each p85alpha/p110 protein required using an excess of the p110 vector over the p85 vector during co-infection of Sf9 cells. Proteins were purified as the p85alpha/p110 complex by nickel affinity chromatography through an N-terminal His-tag on the p110 subunit using an imidazole gradient. The purification yields were high using the optimized ratio of p85/p110 vector and small culture volumes, with 24mg/L cell culture media for p85alpha/p110alpha, 17.5mg/L for p85alpha/p110delta, and 3.5mg/L for p85alpha/p110beta. The identity of each purified isoform was confirmed by mass spectral analysis and immunoblotting. The activities of the three p85alpha/p110 proteins and the Class Ib p110gamma catalytic domain were investigated using phosphatidylinositol 4,5-bisphosphate (PIP2) as the substrate in a PIP2/phosphatidylserine (PS) liposome. All four enzymes exhibited reaction velocities that were dependent on the surface concentration of PIP2. The surface concentrations that gave maximal activity for each human isoform with 0.5mM PIP2 were 2.5mol% PIP2 for p110gamma, 7.5mol% for p85alpha/p110beta, and 10mol% PIP2 for p85alpha/p110alpha and p85alpha/p110delta. The specific activity of p85alpha/p110alpha was three to five times higher than that of the other human isoforms. These kinetic differences may contribute to the unique roles of these isoforms in cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135396     DOI: 10.1016/j.pep.2003.12.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  14 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 2.  Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.

Authors:  Nathan T Ihle; Garth Powis
Journal:  Mol Aspects Med       Date:  2010-02-20

3.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 4.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

5.  Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.

Authors:  Barbara Geering; Pedro R Cutillas; Gemma Nock; Severine I Gharbi; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

6.  Evaluating PI3 kinase isoforms using Transcreener ADP assays.

Authors:  Tony A Klink; Karen M Kleman-Leyer; Andrew Kopp; Thane A Westermeyer; Robert G Lowery
Journal:  J Biomol Screen       Date:  2008-06-19

7.  The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.

Authors:  Julie Guillermet-Guibert; Katja Bjorklof; Ashreena Salpekar; Cristiano Gonella; Faruk Ramadani; Antonio Bilancio; Stephen Meek; Andrew J H Smith; Klaus Okkenhaug; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-10       Impact factor: 11.205

Review 8.  Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases.

Authors:  Rachel Schnur Salamon; Jonathan M Backer
Journal:  Bioessays       Date:  2013-07       Impact factor: 4.345

9.  Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.

Authors:  Claire Chaussade; Gordon W Rewcastle; Jackie D Kendall; William A Denny; Kitty Cho; Line M Grønning; Mei Ling Chong; Sasha H Anagnostou; Shaun P Jackson; Nathalie Daniele; Peter R Shepherd
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

10.  Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis.

Authors:  Jack L Arbiser; Tweeny Kau; Martha Konar; Krishna Narra; Ramani Ramchandran; Scott A Summers; Chris J Vlahos; Keqiang Ye; Betsy N Perry; William Matter; Anthony Fischl; James Cook; Pamela A Silver; Jenny Bain; Philip Cohen; David Whitmire; Scott Furness; Baskaran Govindarajan; J Phillip Bowen
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.